Trial Profile
Phase III trial of amitriptyline/ketamine for the treatment of postherpetic neuralgia.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 07 May 2014
Price :
$35
*
At a glance
- Drugs Amitriptyline/ketamine (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Immune Pharmaceuticals Inc
- 07 May 2014 New trial record